Trial intelligence / Profile preview

LSD for Anxiety

NCT03153579Phase 2Completed

Sponsor
University Hospital Basel
Start
Jun 2017
Primary completion
Dec 2021
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of Lysergide in anxiety disorder, sponsored by University Hospital Basel. Started Jun 2017; status: completed.

02

Drugs

Lysergide
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on NCT03153579.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03153579.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call